Aurora Cannabis (ACB) Cash & Equivalents (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Cash & Equivalents data on file, last reported at $40.4 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $40.4 million, down 57.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $40.4 million (down 57.43% YoY), and the FY2025 annual result was $96.1 million, down 4.83% from the prior year.
• Cash & Equivalents eased to $40.4 million in Q4 2025 per ACB's latest filing, from $69.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $371.5 million in Q1 2021 and troughed at $40.4 million in Q4 2025.
• A 5-year average of $206.0 million and a median of $175.1 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2021 and 2025: Cash & Equivalents jumped 193.14% in 2021, then sank 57.43% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $334.4 million in 2021, then slipped by 5.28% to $316.7 million in 2022, then plunged by 45.51% to $172.6 million in 2023, then slumped by 44.99% to $94.9 million in 2024, then slumped by 57.43% to $40.4 million in 2025.
• Business Quant data shows ACB's Cash & Equivalents at $40.4 million in Q4 2025, $69.5 million in Q3 2025, and $101.2 million in Q2 2025.